Immuno-oncology biotech IDEAYA Biosciences files for a $70 million IPO - (NASDAQ via NewsPoints Desk)

  • In a filing with the US Securities and Exchange Commission, IDEAYA Biosciences said it plans to raise up to $70 million in an initial public offering, reported NASDAQ.

  • The Phase I biotechnology firm is developing targeted immunotherapies for cancer, the news source said.

To read more NewsPoints articles, click here.